Back

Alpha-1 Antitrypsin Limits Neutrophil Extracellular Trap Disruption of Airway Epithelial Barrier Function

Hudock, K. M.; Collins, M. S.; Imbrogno, M. A.; Brewington, J. J.; Ziady, A.; Zhang, N.; Snowball, J. M.; Xu, Y.; Carey, B.; Horio, Y.; O'Grady, S.; Kopras, E.; Meeker, J.; Morgan, H.; Ostmann, A.; Skala, E.; Seifert, M.; Gollomp, K.; Mangalmurti, N.; Trapnell, B.; Clancy, J. P.

2022-03-19 immunology
10.1101/2022.03.18.484920 bioRxiv
Show abstract

Neutrophil extracellular traps contribute to lung injury in cystic fibrosis and asthma, but the mechanisms are poorly understood. We sought to understand the impact of human NETs on barrier function in primary human bronchial epithelial and a human airway epithelial cell line. We demonstrate that NETs disrupt airway epithelial barrier function by decreasing transepithelial electrical resistance and increasing paracellular flux, partially by NET-induced airway cell apoptosis. NETs selectively impact the expression of tight junction genes claudins 4, 8 and 11. Bronchial epithelia exposed to NETs demonstrate visible gaps in E-cadherin staining, a decrease in full-length E-cadherin protein and the appearance of cleaved E-cadherin peptides. Pretreatment of NETs with alpha-1 antitrypsin (A1AT) inhibits NET serine protease activity, limits E-cadherin cleavage, decreases bronchial cell apoptosis and preserves epithelial integrity. In conclusion, NETs disrupt human airway epithelial barrier function through bronchial cell death and degradation of E-cadherin, which are limited by exogenous A1AT. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=156 SRC="FIGDIR/small/484920v2_ufig1.gif" ALT="Figure 1"> View larger version (44K): org.highwire.dtl.DTLVardef@841dbforg.highwire.dtl.DTLVardef@1bd0188org.highwire.dtl.DTLVardef@1afaf97org.highwire.dtl.DTLVardef@130fd03_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
American Journal of Respiratory Cell and Molecular Biology
38 papers in training set
Top 0.1%
23.1%
2
American Journal of Physiology-Lung Cellular and Molecular Physiology
39 papers in training set
Top 0.1%
8.6%
3
PLOS ONE
4510 papers in training set
Top 22%
8.4%
4
JCI Insight
241 papers in training set
Top 0.6%
5.0%
5
Journal of Allergy and Clinical Immunology
25 papers in training set
Top 0.2%
4.7%
6
European Respiratory Journal
54 papers in training set
Top 0.7%
2.1%
50% of probability mass above
7
Frontiers in Pharmacology
100 papers in training set
Top 1%
2.1%
8
The Journal of Infectious Diseases
182 papers in training set
Top 2%
1.9%
9
eLife
5422 papers in training set
Top 37%
1.9%
10
Journal of Clinical Investigation
164 papers in training set
Top 3%
1.8%
11
Scientific Reports
3102 papers in training set
Top 57%
1.7%
12
iScience
1063 papers in training set
Top 19%
1.4%
13
ERJ Open Research
44 papers in training set
Top 0.6%
1.3%
14
Journal of Cystic Fibrosis
15 papers in training set
Top 0.1%
1.3%
15
Biology Open
130 papers in training set
Top 2%
1.1%
16
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 39%
1.0%
17
Thorax
32 papers in training set
Top 0.6%
1.0%
18
Immunology & Cell Biology
11 papers in training set
Top 0.1%
1.0%
19
Frontiers in Immunology
586 papers in training set
Top 6%
1.0%
20
Frontiers in Physiology
93 papers in training set
Top 5%
0.9%
21
Allergy
23 papers in training set
Top 0.5%
0.9%
22
American Journal of Respiratory and Critical Care Medicine
39 papers in training set
Top 0.8%
0.8%
23
Cells
232 papers in training set
Top 5%
0.8%
24
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 8%
0.8%
25
Science Translational Medicine
111 papers in training set
Top 6%
0.8%
26
Inflammatory Bowel Diseases
15 papers in training set
Top 0.3%
0.8%
27
Journal of Biological Chemistry
641 papers in training set
Top 4%
0.8%
28
Mucosal Immunology
42 papers in training set
Top 0.3%
0.8%
29
Frontiers in Cellular Neuroscience
79 papers in training set
Top 1%
0.8%
30
Immunology
29 papers in training set
Top 1.0%
0.8%